US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist
  • 10.530
  • 0.0000.00%
Close Jul 24 16:00 ET
  • 10.530
  • 0.0000.00%
Post 16:30 ET
184.89MMarket Cap-9572P/E (TTM)

Rigel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rigel Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

29.53M

+13.29%
EPS(YoY)

-0.50

+37.50%
Analyst Rating

Buy

Jun 30, 2024

Rigel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 39.876M--
--2024/Q2-- / 33.704M--
May 7, 20242024/Q129.534M / 31.472M--
Mar 5, 20242023/Q435.792M / 33.415M--
Nov 7, 20232023/Q328.134M / 27.201M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 39.876M--
--2024/Q2-- / 33.704M--
May 7, 20242024/Q129.534M / 31.472M--
Mar 5, 20242023/Q435.792M / 33.415M--
Nov 7, 20232023/Q328.134M / 27.201M--

Unlock Free Earnings Estimates

Rigel Pharmaceuticals Earnings Reports

  • Rigel Pharmaceuticals | 10-Q: Quarterly report

    May 7 16:58 ET

  • Rigel Pharmaceuticals | 10-K: Annual report

    Mar 5 16:09 ET

  • Rigel Pharmaceuticals: Q3 2023 Earnings Report

    Nov 7, 2023 16:05 ET

  • Rigel Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 1, 2023 16:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg